Search results
US challenges 'bogus' patents on Ozempic, other drugs in effort to spur competition
Pittsburgh Tribune-Review· 2 days agoFederal regulators are challenging patents on 20 brand-name drugs, including the blockbuster...
U.S. challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
Pittsburgh Tribune-Review· 2 days agoFederal regulators are challenging patents on 20 brand name drugs, including the blockbuster...
FTC cracks down on drugmaker patents, including Novo's Ozempic; analysts weigh in By Investing.com
Investing.com· 2 days agoOn Tuesday, the Federal Trade Commission (FTC) said it is challenging hundreds of what it calls...
When supplies resume, should governments subsidise drugs like Ozempic for weight loss? We asked 5...
The Conversation· 3 days agoNeither Ozempic nor Wegovy are listed on the PBS to treat obesity. When Wegovy becomes available, users will need to pay the full price. Or should the government subsidise it?
Sanders Launches Senate Investigation into Sky-High Ozempic and Wegovy Drug Prices
Homenewshere.com· 7 days agoSenator Bernie Sanders launched a Senate investigation into the "outrageously high prices" of...
Novo’s Blockbuster Ozempic Among FTC’s Latest Patent Targets
Bloomberg Law· 2 days agoOzempic and Victoza are among 20 branded drugs the Federal Trade Commission is targeting as it challenges more than 300 “junk patent listings” in the FDA’s registry of approved ...
Mastercard Cuts Forecast, Network Spending Misses Estimates
Bloomberg via Yahoo Finance· 18 hours ago...Saudis Near Defense Pact Meant to Reshape Middle EastTesla Axes Supercharger Team in Blow to...
Weight-loss drug coverage for Illinois state workers could cost hundreds of millions of dollars
Chicago Sun-Times· 2 days agoThe results can be akin to bariatric surgery but at a prohibitive cost — in some cases, more than $16,000 a year. In making highly sought-after injectable medications like ...
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
Quartz· 2 days agoFederal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration ...
Shell Beat Forecasts on Improved Asset Utilization
The Wall Street Journal· 2 hours agoCiti said Shell’s beat to first-quarter net income was for the most part driven by better utilization across key assets—such as the Prelude LNG platform,...